Latvian State Drug Agency and Health Inspectorate with a special permit released newly produced batch of RIGVIR medicine for sale in Latvia, so RIGVIR is now available again for patients in Latvia. At the same time registration of Rigvir in Latvia is now temporarily postponed in order to ensure improvements in validation of the new testing methods of RIGVIR in accordance with State Drug Agency requirements.
Meanwhile, Rigvir is also available for patients interested in this kind of oncolytic virotherapy in other countries where RIGVIR obtained national registrations. Medicine is registered in Georgia, Armenia and Uzbekistan and these registrations are in power and not being compromised.
Jumeirah Lake Towers
Swiss Tower, office 204
P.O. Box 309073, Dubai, UAE
+ 44 20 38 684 002 (UK, London)
+ 1 646 88 33 419 (USA, New York)
+ 371 67 229 599 (Latvia)
© 2019 International Virotherapy Center Limited. All Rights Reserved
Ltd State of Well (Reg.Nr. 40203172199) on a base of Licence and Cooperation Agreement (No. IVC-SW-02.01.2019), signed January 2nd, 2019 is legally responsible for the content of the website www.virotherapy.eu